Keywords: pharming, prodarsan, enters, ph, testing, leiden, netherlands-based

Pharming's Prodarsan enters Ph I testing

Article | 05 May 2008

Leiden, the Netherlands-based biotechnology company Pharming says that its wholly-owned subsidiary DNage has started a Phase I clinical study to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing